MannKind CEO purchases 100,000 shares; stock climbs [Seeking Alpha]
MannKind Corporation (MNKD)
Last mannkind corporation earnings: 2/25 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.mannkindcorp.com/press-releases
Company Research
Source: Seeking Alpha
The shares were purchased on March 10, 2026, at a price of $2.59 per share. The transaction increased Castagna's direct ownership to 2.58M shares. MNKD shares up 7.7%. Fresh Stock Ideas, Every Day Explore diverse investing perspectives with daily analysis from experts across the market. Subscribe to Stock Ideas Sign Up More on MannKind Furoscix Growth Versus Tyvaso Royalties: Assessing MannKind's Future MannKind Corporation 2025 Q4 - Results - Earnings Call Presentation MannKind Corporation (MNKD) Q4 2025 Earnings Call Transcript MannKind outlines $450M 2026 revenue run rate and key product catalysts amid Afrezza pediatric launch preparations MannKind hits 52-week low after Q4 earnings miss
Show less
Read more
Impact Snapshot
Event Time:
MNKD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MNKD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MNKD alerts
High impacting MannKind Corporation news events
Weekly update
A roundup of the hottest topics
MNKD
News
- MannKind: Strategic Uncertainty Follows United Therapeutics' Pivot (Rating Downgrade) [Seeking Alpha]Seeking Alpha
- MannKind (MNKD) was downgraded by Zacks Research from "hold" to "strong sell".MarketBeat
- MannKind Corporation (MNKD) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]Seeking Alpha
- MannKind to Present New Data From Pediatric and Adult Studies of Afrezza® at ATTD 2026 [Yahoo! Finance]Yahoo! Finance
- MannKind to Present New Data From Pediatric and Adult Studies of Afrezza® at ATTD 2026GlobeNewswire
MNKD
Earnings
- 2/26/26 - Beat
MNKD
Sec Filings
- 3/10/26 - Form 4
- 3/3/26 - Form 4
- 3/3/26 - Form 4
- MNKD's page on the SEC website